What Happened

According to a Crunchbase News analysis published June 25, 2026, US acquirers have spent at least $119.8 billion buying venture-backed private companies so far this year — putting 2026 on pace to exceed 2025's record-setting M&A total.

The headline deal is SpaceX's $60 billion acquisition of Anysphere, the parent company of AI coding tool Cursor. SpaceX first announced an option to purchase the company in April 2026 and consummated the deal following its IPO this month. The transaction is the largest startup acquisition in history, nearly doubling Google's $32 billion acquisition of Wiz and more than tripling Facebook's $19 billion WhatsApp deal from 2014.

Roughly half of all 2026 US startup M&A spending comes from this single transaction. The remaining top 10 disclosed deals range from $2 billion to $7 billion:

1. Eli Lilly / Kelonia Therapeutics — up to $7 billion (gene therapies, cancer focus)
2. Capital One / Brex — $5.15 billion (business credit cards and accounts)
3. Qualcomm / Modular — $4 billion (AI chip startup, announced June 24)
4. Salesforce / Fin — $3.6 billion (AI customer experience tools)
5. Autodesk / MaintainX — $3.6 billion (industrial AI platform)
6. Eli Lilly / Orna Therapeutics — up to $2.4 billion (RNA therapeutics)
7. Eli Lilly / Ajax Therapeutics — up to $2.3 billion (blood cancer therapies)

Half of the top 10 deals were biotech transactions. In most biotech cases, the headline number represents the maximum potential acquisition price, contingent on the acquired company meeting predetermined clinical and commercialization milestones.

Why It Matters

The Cursor deal does more than set a record — it redefines the exit landscape for AI startups. A $60 billion acquisition by a non-traditional software acquirer (SpaceX) signals that strategic value in AI tooling now extends far beyond the usual suspects in big tech. For founders, this means exit conversations may start earlier and at higher valuations than historical comps suggest.

The broader M&A surge also reveals acquirer behavior: corporates are buying capabilities rather than building them. Qualcomm's $4 billion Modular acquisition, announced just yesterday, underscores that AI chip infrastructure is a hot acquisition category. Capital One's $5.15 billion Brex deal shows fintech consolidation continues at scale. And Eli Lilly's three deals in the top 10 demonstrate that pharma is deploying capital aggressively through milestone-structured transactions.

For operators, the key takeaway is that the M&A window is wide open across multiple sectors simultaneously — not just AI. This compresses decision timelines for startups weighing whether to raise another round or pursue an exit.

Who Is Affected

AI startup founders in developer tools, infrastructure, and enterprise SaaS should recalibrate exit expectations. The Cursor deal establishes a new ceiling for AI tooling valuations and will likely drive acquirers to approach earlier with larger offers.

Corporate development teams across pharma, fintech, semiconductors, and enterprise software are clearly active and competing for quality assets. The breadth of the top 10 — spanning biotech, fintech, AI chips, CX tools, and industrial AI — indicates broad-based demand.

Biotech investors and operators should note that pharma giants are using milestone-based deal structures to deploy capital at scale while managing clinical risk. Eli Lilly alone accounted for three of the top 10 deals.

Strategic Implications

For AI Startup Founders

The Cursor deal sets a new reference point for AI tooling valuations in M&A discussions. If you're building in developer productivity or AI infrastructure, expect acquirers to approach earlier and with larger check sizes — but also expect heightened scrutiny on revenue quality, customer concentration, and defensibility. The $60B headline is an outlier; the next-largest AI deal in the top 10 (Modular at $4B) is a more realistic benchmark for most founders.

For Developers/Operators Building with AI APIs

Qualcomm's $4B acquisition of Modular signals consolidation in the AI chip layer, which could affect the roadmap and pricing of AI inference infrastructure. If you depend on Modular or similar chip-layer tools, monitor for product roadmap changes, pricing shifts, or integration with Qualcomm's broader portfolio post-close. Similarly, Salesforce's acquisition of Fin could mean CX AI capabilities get bundled into Salesforce's platform — affecting standalone vendors in that space.

For Non-Technical Business Owners Evaluating AI Tools

Salesforce's acquisition of Fin and Autodesk's acquisition of MaintainX suggest AI capabilities in customer experience and industrial operations are being absorbed into established enterprise platforms. If you're evaluating standalone AI tools in these categories, consider whether the vendor is an acquisition target — and what that means for your pricing, integration path, and long-term vendor relationship.

What to Watch Next

With Q2 2026 winding down, Crunchbase notes that additional large deals could still close before quarter-end. Watch for follow-on M&A activity in AI infrastructure (particularly chip and inference layer startups), continued pharma consolidation, and any ripple effects from the SpaceX-Cursor deal on AI coding tool competitors.

Frequently Asked Questions

Q: How much did SpaceX pay for Cursor (Anysphere)?

A: SpaceX acquired Anysphere, the parent company of AI coding tool Cursor, for $60 billion. The deal was first announced as an option in April 2026 and consummated after SpaceX's IPO in June 2026. It is the largest startup acquisition in history.

Q: What are the largest startup M&A deals of 2026 so far?

A: The top deals include SpaceX's $60B acquisition of Cursor, Eli Lilly's up to $7B acquisition of Kelonia Therapeutics, Capital One's $5.15B acquisition of Brex, Qualcomm's $4B acquisition of Modular, and Salesforce and Autodesk each closing $3.6B deals for Fin and MaintainX respectively. Total US startup M&A spending reached at least $119.8 billion.

Q: Is 2026 on pace for a record M&A year?

A: Yes. According to Crunchbase, the $119.8 billion spent so far in 2026 puts the year on pace to exceed 2025's record-setting total, though roughly half of 2026 spending comes from the single SpaceX-Cursor transaction.